Resistance to Nonnucleoside Reverse-Transcriptase Inhibitors and Prevalence of HIV Type 1 Non-B Subtypes Are Increasing among Persons with Recent Infection in Spain | Zendy

Carmen de Mendoza | Zendy; Carly A. Rodriguez | Zendy; Javier Colomina | Zendy; C. Tuset | Zendy; Féderico García | Zendy; José Marı́a Eiros Bouza | Zendy; Angélica Corral | Zendy; Pilar Suarez Leiva | Zendy; Jesús Agüero | Zendy; José Miguel Cisneros | Zendy; J. Pedreira | Zendy; Isabel Viciana | Zendy; Jorge del Romero | Zendy; Alicia Sáez | Zendy; Raúl Ortíz de Lejarazu | Zendy; Vincent Soriano | Zendy

Open Access

Resistance to Nonnucleoside Reverse-Transcriptase Inhibitors and Prevalence of HIV Type 1 Non-B Subtypes Are Increasing among Persons with Recent Infection in Spain

Author(s) -

Carmen de Mendoza,

Carly A. Rodriguez,

Javier Colomina,

C. Tuset,

Féderico García,

José Marı́a Eiros Bouza,

Angélica Corral,

Pilar Suarez Leiva,

Jesús Agüero,

José Miguel Cisneros,

J. Pedreira,

Isabel Viciana,

Jorge del Romero,

Alicia Sáez,

Raúl Ortíz de Lejarazu,

Vincent Soriano

Publication year - 2005

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/496982

Subject(s) - seroconversion , medicine , virology , human immunodeficiency virus (hiv) , drug resistance , reverse transcriptase , viral disease , transmission (telecommunications) , lentivirus , sida , immunology , polymerase chain reaction , biology , microbiology and biotechnology , genetics , gene , electrical engineering , engineering

The prevalence of drug resistance mutations was 12.1% among 198 persons who experienced human immunodeficiency virus (HIV) seroconversion identified in Spain during 1997-2004. There was a significant increase of K103N and of non-B subtypes over time. Transmission of HIV infection around the time of seroconversion was shown in 8 couples and in 2 clusters of 3 individuals.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research